Literature DB >> 8395523

Increased synthesis and degradation of DNA topoisomerase I during the initial phase of human T lymphocyte proliferation.

C L Hwong1, C Y Chen, H F Shang, J Hwang.   

Abstract

The regulation of DNA topoisomerase I was studied in human T lymphocytes following phytohemagglutinin (PHA) stimulation. As T lymphocytes began to enter the S phase 24 h after stimulation, there was a rapid increase in DNA topoisomerase I mRNA. The level of DNA topoisomerase I mRNA increased continuously over the next 18 h and peaked (> 50-fold increase) 42 h after stimulation with PHA. A concomitant increase in DNA topoisomerase I protein was also observed. However, the maximal increase in DNA topoisomerase I protein was only 6-fold. To explain the quantitative difference between the mRNA and protein levels, we investigated the change in the rates of DNA topoisomerase I protein synthesis versus degradation in human T lymphocytes following PHA stimulation. The increase in the mRNA parallels the increase in protein synthesis. However, the half-life of the enzyme protein was reduced to 9 h in proliferating T lymphocytes compared to a half-life of 36 h in resting lymphocytes. These results indicate that, in addition to the growth-regulated increase in the expression of DNA topoisomerase I, there was also a concomitant increase in the degradation of DNA topoisomerase I protein.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8395523

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  Par-4 binds to topoisomerase 1 and attenuates its DNA relaxation activity.

Authors:  Anindya Goswami; Shirley Qiu; Thomas S Dexheimer; Padhma Ranganathan; Ravshan Burikhanov; Yves Pommier; Vivek M Rangnekar
Journal:  Cancer Res       Date:  2008-08-01       Impact factor: 12.701

Review 2.  DNA topoisomerase I in oncology: Dr Jekyll or Mr Hyde?

Authors:  A K Larsen; C Gobert
Journal:  Pathol Oncol Res       Date:  1999       Impact factor: 3.201

3.  Immunohistochemical detection of DNA topoisomerase I in formalin fixed, paraffin wax embedded normal tissues and in ovarian carcinomas.

Authors:  J A Holden; M P Rahn; C J Jolles; S V Vorobyev; I B Bronstein
Journal:  Mol Pathol       Date:  1997-10

4.  Detection and sequence analysis of hepatitis B virus integration in peripheral blood mononuclear cells.

Authors:  T Laskus; M Radkowski; L F Wang; M Nowicki; J Rakela
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

5.  The human topoisomerase I gene promoter is regulated by NF-IL6.

Authors:  S Heiland; R Knippers
Journal:  Mol Cell Biol       Date:  1995-12       Impact factor: 4.272

Review 6.  Topoisomerase I inhibitors: the relevance of prolonged exposure for present clinical development.

Authors:  C J Gerrits; M J de Jonge; J H Schellens; G Stoter; J Verweij
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

7.  Evodiamine stabilizes topoisomerase I-DNA cleavable complex to inhibit topoisomerase I activity.

Authors:  Agnes L-F Chan; Wen-Shin Chang; Li-Min Chen; Chi-Ming Lee; Chiao-En Chen; Chun-Mao Lin; Jau-Lang Hwang
Journal:  Molecules       Date:  2009-03-27       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.